Article
San Diego-Artes Medical received an approvable letter for ArteFill from the U.S. Food and Drug Administration (FDA) on January 16, 2004.
New Study Examines Connection Between Formulation and Benzene Levels in BPO Products
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
The Complex World of Urticaria: Insights from Jason Hawkes, MD, MS
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Post-Hoc Analysis of ALLEGRO-2b/3 Trial Highlights Patient-Reported Outcome Improvements
Should “Advanced Practice Provider” Represent Both PAs and NPs?